I love sifting through micro-caps in the hunt for under-followed
companies that have a lot to offer to patient investors. Unfortunately, I
think I'm late to the party with Utah Medical (UTMD)
as although this company is not followed by the sell-side, the shares
are up more than 50% over the past year and nearly 100% over the past
two years.
Utah Medical has a long history of excellent margins and free cash flow generation (better, even, that established giants like Bard (BCR) and Medtronic (MDT)),
but not a lot in the way of revenue growth. While an acquisition a
little while ago gave the company a great growth product, it looks like
management needs to consider going back to the M&A well to take this
business to another level.
Please read more here:
Utah Medical Has Appealing Quality, But Needs Growth
No comments:
Post a Comment